Back to search
FDAFDA · Food and drugs·Recall number D-0184-2021

Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02

Published January 6, 2021 · Recall initiated: December 17, 2020

Summary

FDA records drug Class II recall D-0184-2021, published January 6, 2021 and initiated December 17, 2020. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 490,633 vials; Lot: Batch # 6121125, Exp 02/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter - found in reserve sample vials at the firm.

What to do

Voluntary: Firm initiated · Letter

Get an email if KETOROLAC TROMETHAMINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
KETOROLAC TROMETHAMINE
Manufacturer
Fresenius Kabi USA, LLC
Distributor
USA Nationwide and Puerto Rico
UPC
0363323162115
Lot
Batch # 6121125, Exp 02/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02 recalled?

Yes. FDA published recall D-0184-2021 on January 6, 2021. Reported hazard: Presence of Particulate Matter - found in reserve sample vials at the firm.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: KETOROLAC TROMETHAMINE. UPC: 0363323162115.